93M1 Stock Overview
An investment company, engages in the healthcare business in Germany.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
MPH Health Care AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €20.60 |
52 Week High | €35.60 |
52 Week Low | €13.85 |
Beta | 1.16 |
11 Month Change | -17.60% |
3 Month Change | -21.37% |
1 Year Change | 34.20% |
33 Year Change | -24.82% |
5 Year Change | -47.04% |
Change since IPO | -17.63% |
Recent News & Updates
Recent updates
If You Had Bought MPH Health Care's (ETR:93M) Shares A Year Ago You Would Be Down 28%
Aug 10What Type Of Returns Would MPH Health Care's(ETR:93M) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Aug 10We Think MPH Health Care's (ETR:93M) Statutory Profit Might Understate Its Earnings Potential
Jul 06Shareholder Returns
93M1 | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 1.0% | 3.4% | 2.8% |
1Y | 34.2% | -14.3% | 4.1% |
Return vs Industry: 93M1 exceeded the German Pharmaceuticals industry which returned -14.3% over the past year.
Return vs Market: 93M1 exceeded the German Market which returned 4.1% over the past year.
Price Volatility
93M1 volatility | |
---|---|
93M1 Average Weekly Movement | 9.6% |
Pharmaceuticals Industry Average Movement | 5.1% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 93M1's share price has been volatile over the past 3 months.
Volatility Over Time: 93M1's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 2 | Patrick Brenske | www.mph-ag.de |
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. The company operates Beauty, Pharma, and Real Estate segments. It offers medicalaesthetic beauty operations and treatments, as well as the operation and provision of medical infrastructures for partner companies; and pharmaceuticals and medical products in the therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine.
MPH Health Care AG Fundamentals Summary
93M1 fundamental statistics | |
---|---|
Market cap | €89.05m |
Earnings (TTM) | €29.54m |
Revenue (TTM) | €34.43m |
3.0x
P/E Ratio2.6x
P/S RatioIs 93M1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
93M1 income statement (TTM) | |
---|---|
Revenue | €34.43m |
Cost of Revenue | €0 |
Gross Profit | €34.43m |
Other Expenses | €4.89m |
Earnings | €29.54m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 05, 2024
Earnings per share (EPS) | 6.90 |
Gross Margin | 100.00% |
Net Profit Margin | 85.81% |
Debt/Equity Ratio | 3.3% |
How did 93M1 perform over the long term?
See historical performance and comparison